文献速递临床试验与 GCP医学人工智能与信息学流行病学与生物统计

人工智能辅助整合照护促进中国结肠镜筛查接受度的整群随机对照试验方案

Artificial intelligence-assisted integrated care to promote colonoscopy uptake (AICC) in China: study protocol for a cluster randomized controlled trial.
PubMed 文献 · Trials · 2026-05-18

本研究为在中国山东省开展的二臂平行整群随机对照试验,拟从40个社区/村招募400名40-64岁结直肠癌高危居民,比较人工智能辅助整合照护与专科照护对结肠镜接受度的影响。主要结局为干预后3个月和6个月的结肠镜接受率及至结肠镜时间。

要点

  • 在中国高危人群中比较AI辅助整合照护与专科照护对结肠镜接受度的影响。
  • 主要结局为干预后3个月和6个月结肠镜接受率及至结肠镜时间。
  • 同时开展过程评价和卫生经济学评价。

核心结论

  • 该试验旨在评估AI辅助整合照护相较专科照护能否提高中国结直肠癌高危个体的结肠镜接受度。

研究设计与样本

  • 二臂平行整群随机对照试验,计划从山东省一个城区和两个农村县40个社区/村招募400名40-64岁结直肠癌高危居民。
  • 以社区/村为整群在县内随机分配至专科照护组或AI辅助整合照护组。
  • 参与者为经风险评估问卷或粪便免疫化学试验初筛判定为结直肠癌高危者。

关键数值与推荐

  • 主要结局为干预后3个月和6个月结肠镜接受率及至结肠镜时间。
  • 次要结局包括结直肠癌筛查素养、信念和接受结肠镜的意向。

临床怎么用

  • 若证实有效,该策略可为将多学科团队与数字健康方案结合以提高结肠镜接受度提供可行路径。
  • 研究结果可为推进中国癌症预防与控制工作提供实践参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Colorectal cancer (CRC) leads to heavy disease and economic burdens globally. Early screening such as colonoscopy has been demonstrated to reduce both CRC incidence and mortality. However, uptake of colonoscopy among high-risk individuals is low in China, limiting screening efficacy. To improve screening uptake, it is necessary to ensure the engagement of both specialist and general practitioners. And recently, AI techniques show considerable promise in delivering personalized health education. This study aims to evaluate the effectiveness of AI-assisted integrated care, compared with specialty care in improving uptake of colonoscopy among CRC high-risk individuals in China. METHODS: A two-arm, parallel cluster randomized controlled trial will enroll 400 high-risk residents for CRC aged 40-64 years from 40 communities/villages across one urban district and two rural counties in Shandong Province, China. Communities/villages as clusters will be randomized within counties to either a specialty care group or an AI-assisted integrated care group. Participants will be those initially identified as high risk for CRC through a risk assessment questionnaire or fecal immunochemical test. The primary outcomes are colonoscopy uptake at 3 and 6 months post-intervention and the time to colonoscopy. Secondary outcomes encompass CRC screening literacy, beliefs, and intention to undergo colonoscopy. Additionally, we will also conduct a process evaluation and health economic evaluation. DISCUSSION: This study proposes a novel strategy integrating a multidisciplinary team with digital health solutions. We expect that this strategy will provide a feasible approach to improve colonoscopy uptake. The findings could offer practical insights for informing and advancing cancer prevention and control initiatives in China. TRIAL REGISTRATION: ClinicalTrial.gov NCT07261059 . Registered on December 2, 2025.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wang X, Zhou H, Zhang N, et al. Artificial intelligence-assisted integrated care to promote colonoscopy uptake (AICC) in China: study protocol for a cluster randomized controlled trial. Trials. 2026. PMID: 42152022. doi:10.1186/s13063-026-09764-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。